These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 18184409

  • 1. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z, Ye Y, Chen D, Shen D, Xu F, Cui Z, Wang S.
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
    Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M.
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
    [Abstract] [Full Text] [Related]

  • 6. PTEN expression and suppression of proliferation are associated with Cdx2 overexpression in gastric cancer cells.
    Bai ZG, Ye YJ, Shen DH, Lu YY, Zhang ZT, Wang S.
    Int J Oncol; 2013 May; 42(5):1682-91. PubMed ID: 23546539
    [Abstract] [Full Text] [Related]

  • 7. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
    Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K, Takenoshita S.
    Oncol Rep; 2009 Oct; 22(4):745-55. PubMed ID: 19724852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas.
    Matsumoto K, Mizoshita T, Tsukamoto T, Ogasawara N, Hirata A, Shimizu Y, Haneda M, Yamao K, Tatematsu M.
    Oncol Rep; 2004 Dec; 12(6):1239-43. PubMed ID: 15547744
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
    Seno H, Oshima M, Taniguchi MA, Usami K, Ishikawa TO, Chiba T, Taketo MM.
    Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M.
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.
    Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupold JH, Hohenberger W, Allgayer H.
    Adv Med Sci; 2014 Mar; 59(1):142-6. PubMed ID: 24797991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma].
    Zheng HC, Chen Y, Kuang LG, Yang L, Li JY, Wu DY, Zhang SM, Xin Y.
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):13-6. PubMed ID: 12678979
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.